| Anti-HCV (+) (n = 23) | Anti-HCV (−) (n = 34) | Statistics (p) |
Gender (Males/Females) | 14/9 | 19/15 | 0.916 |
Age (years) | 46.4 ± 11.8 | 45.8 ± 13.4 | 0.8676 |
Time on hemodialysis (years) | 10.6 ± 7.7 | 4.5 ± 3 | 0.0022 |
Primary renal disease | 17 | 28 | 0.1055 |
Primary glomerular disease | 8 | 12 |
|
Diabetic nephropathy | 0 | 3 |
|
Secondary amyloidosis | 1 | 0 |
|
Lupus nephritis | 2 | 0 |
|
Interstitial nephritis | 4 | 6 |
|
Polycystic kidney disease | 2 | 1 |
|
Hypertensive nephropathy | 0 | 6 |
|
Unknown | 6 | 6 |
|
Vasoactive drug | 10 | 17 | 0.6291 |
Calcium channel antagonist | 7 | 10 | 0.057 |
β-blocker | 0 | 3 | 0.297 |